National Comprehensive Cancer Network



About NCCN

Acute Lymphoblastic Leukemia Panel - Disclosures as of 1/9/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Attendance

Joseph C. Alvarnas, MD

Clinical Trials Network

None

None

None

None

Patricia Aoun, MD, MPH

None

None

None

None

None

Karen Kuhn Ballen, MD

None

None

None

None

None

Naresh Bellam, MD, MPH

None

None

None

None

None

William Blum, MD

None

None

None

None

None

Michael W. Boyer, MD

None

None

None

None

None

Patrick A. Brown, MD

None

None

None

None

None

Hetty E. Carraway, MD

None

None

None

None

None

Peter F. Coccia, MD

None

None

None

None

None

Steven E. Coutre, MD

None

Celgene Corporation;
Novartis Pharmaceuticals Corporation

None

None

None

Lloyd E. Damon, MD

None

None

None

None

None

Daniel J. DeAngelo, MD, PhD

None

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation;
Sigma-Tau Pharmaceuticals, Inc.

None

None

None

Dan Douer, MD

None

Enzon Pharmaceuticals

None

None

None

Haydar Frangoul, MD

None

None

None

None

None

Olga Frankfurt, MD

None

None

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Robert A. Johnson, MD, FACP

None

None

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Michael M. Millenson, MD, FACP

None

None

None

None

sanofi-aventis U.S.

Susan O'Brien, MD

None

Hana Biosciences, Inc.

None

None

None

Arati V. Rao, MD

None

None

None

None

None

Bijal Shah, MD

None

None

None

None

None

Andrei R. Shustov, MD

Talon Therapeutics;
Pfizer Inc.

None

None

None

None

Stephanie Terezakis, MD

None

None

None

None

None

Geoffrey Uy, MD

None

Genzyme Corporation

None

None

None

Meir Wetzler, MD

None

Amgen Inc.;
Teva

None

None

None

Andrew D. Zelenetz, MD, PhD

None

Abbott Laboratories;
Celgene Corporation;
Cell Therapeutics, Inc.;
Cephalon, Inc.;
Genentech, Inc.;
GlaxoSmithKline;
Allos;
Cancer Genetics;
Gilead;
Seattle Genetics;
Roche Laboratories, Inc.;
sanofi-aventis U.S.

None

None

None